Dihydroartemisinin represses esophageal cancer glycolysis by down-regulating pyruvate kinase M2

Shumin Li1, Peng Huang1, Junqing Gan1

  • 1Department of Gastrointestinal Oncology, Harbin Medical University Cancer Hospital, Harbin, Heilongjiang, 150081, PR China.

Insights

Dihydroartemisinin (DHA) shows promise against esophageal squamous cell carcinoma (ESCC) by inhibiting cancer cell glycolysis. This novel therapy targets pyruvate kinase M2 (PKM2), a key factor in ESCC progression.

Area of Science:

  • Oncology
  • Biochemistry
  • Pharmacology

Background:

  • Esophageal squamous cell carcinoma (ESCC) poses a significant health burden, particularly in China, with limited treatment options.
  • Previous research indicated dihydroartemisinin (DHA) possesses anticancer properties against esophageal cancer, but the underlying mechanisms remain unclear.
  • Cancer cells often exhibit altered metabolism, including enhanced glycolysis (the Warburg effect), which supports rapid proliferation.

Purpose of the Study:

  • To investigate the effect of dihydroartemisinin (DHA) on cancer cell glycolysis in esophageal squamous cell carcinoma (ESCC).
  • To explore the role of pyruvate kinase M2 (PKM2), a key regulator of glycolysis, in the context of DHA treatment for ESCC.
  • To determine if targeting PKM2 mediates the anti-glycolytic effects of DHA in ESCC.

Main Methods:

  • Assessed the expression levels of pyruvate kinase M2 (PKM2) in ESCC patient samples and cell lines.
  • Treated ESCC cells with dihydroartemisinin (DHA) and measured changes in PKM2 expression, glucose uptake, and lactate production.
  • Utilized lentiviral transfection to overexpress PKM2 in ESCC cells to evaluate its impact on DHA's inhibitory effects.

Main Results:

  • Pyruvate kinase M2 (PKM2) was found to be significantly overexpressed in ESCC patients and cell lines.
  • DHA treatment led to down-regulation of PKM2, reduced glucose uptake, and inhibited lactate production in ESCC cells.
  • Overexpression of PKM2 counteracted the inhibitory effects of DHA on glycolysis, suggesting PKM2 mediates DHA's action.

Conclusions:

  • Dihydroartemisinin (DHA) exhibits anti-glycolytic effects in esophageal squamous cell carcinoma (ESCC) partly through the down-regulation of pyruvate kinase M2 (PKM2).
  • Targeting PKM2 represents a potential therapeutic strategy for managing ESCC.
  • DHA holds promise as a prospective therapeutic agent for esophageal cancer treatment.

Related Concept Videos

Energy-releasing Steps of Glycolysis01:28

Energy-releasing Steps of Glycolysis

Glycolysis is divided into two phases based on whether energy is utilized or released. While the first phase consumes ATP, the second phase produces energy in the form of ATP and NADH. The energy is released over a sequence of reactions that turns G3P into pyruvate. The energy-releasing phase—steps 6-10 of glycolysis—occurs twice, once for each of the two 3-carbon sugars produced during steps 1-5 of the first phase.
The first energy-releasing step—the 6th step of glycolysis...
146.5K
Outcomes of Glycolysis01:13

Outcomes of Glycolysis

Nearly all the energy used by cells comes from the bonds that make up complex organic compounds. These organic compounds are broken down into simpler molecules, such as glucose. As a result, cells extract energy from glucose over many chemical reactions—a process called cellular respiration.
Cellular respiration can occur aerobically (with oxygen) or anaerobically (without oxygen). In the presence of oxygen, cellular respiration starts with glycolysis and continues with pyruvate...
106.8K
Pyruvate Oxidation01:15

Pyruvate Oxidation

After glycolysis, the charged pyruvate molecules enter the mitochondria via active transport and undergo three enzymatic reactions. These reactions ensure that pyruvate can enter the next metabolic pathway so that energy stored in the pyruvate molecules can be harnessed by the cells.
First, the enzyme pyruvate dehydrogenase removes the carboxyl group from pyruvate and releases it as carbon dioxide. The stripped molecule is then oxidized and releases electrons, which are then picked up by NAD+...
168.5K
What is Glycolysis?00:56

What is Glycolysis?

Overview
Cells make energy by breaking down macromolecules. Cellular respiration is the biochemical process that converts "food energy" (from the chemical bonds of macromolecules) into chemical energy in the form of adenosine triphosphate (ATP). The first step of this tightly regulated and intricate process is glycolysis. The word glycolysis originates from the Latin glyco (sugar) and lysis (breakdown). Glycolysis serves two main intracellular functions: generating ATP and generating...
176.6K
Energy-requiring Steps of Glycolysis01:20

Energy-requiring Steps of Glycolysis

Glucose is the source of nearly all energy used by organisms. The first step of converting glucose into usable energy is called glycolysis. Glycolysis occurs in the cytosol of the cell over two phases: an energy-requiring phase and an energy-releasing phase. Over the first three steps, glucose is converted into different forms and attached to two phosphate groups donated by two ATP molecules, resulting in an unstable sugar. In the next two stages, the unstable sugar splits into two sugar...
171.4K
Protein Kinases and Phosphatases02:54

Protein Kinases and Phosphatases

Proteins undergo chemical modifications that trigger changes in the charge, structure, and conformation of the proteins. Phosphorylation, acetylation, glycosylation, nitrosylation, ubiquitination, lipidation, methylation, and proteolysis are various protein modifications that regulate protein activity. Such modifications are usually enzyme-driven.
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
15.0K